ENT Updates

Original Article

The Diagnostic Value of Serum Eosinophil Cationic Protein for Aspirin Intolerance in Patients with Chronic Rhinosinusitis

Downloads

https://doi.org/10.5152/entupdates.2021.866215
Rida Abuzinadah, H., Yaseen Albar, N., Tisch, M., & Muehlmeier, G. (2021). The Diagnostic Value of Serum Eosinophil Cationic Protein for Aspirin Intolerance in Patients with Chronic Rhinosinusitis. ENT Updates, 11(1). https://doi.org/10.5152/entupdates.2021.866215
Volume 11 Issue 1 (2021)
Copyright (c) 2021 Haythem Rida Abuzinadah, Naif Yaseen Albar, Matthias Tisch, Guido Muehlmeier
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors

  • Haythem Rida Abuzinadah
    Department of Otorhinolaryngology, Head and Neck Surgery, King Abdulaziz University College of Medicine and King Abdulaziz University Hospital, Jeddah, Saudi Arabia; Department of Otorhinolaryngology, Head and Neck Surgery, German Armed Forces Hospital, Ulm, Germany
  • Naif Yaseen Albar Department of Otorhinolaryngology, Head and Neck Surgery, German Armed Forces Hospital, Ulm, Germany; Department of Otorhinolaryngology, Head and Neck Surgery, King Abdulaziz University College of Medicine, Rabigh, Saudi Arabia
  • Matthias Tisch Department of Otorhinolaryngology, Head and Neck Surgery, German Armed Forces Hospital, Ulm, Germany
  • Guido Muehlmeier Department of Otorhinolaryngology, Head and Neck Surgery, German Armed Forces Hospital, Ulm, Germany

Objective: Aspirin intolerance (AI) is one of the endotypes of chronic rhinosinusitis (CRS) that can be effectively treated if detected early. Considering the limitations of the available tests for AI, there is still a need for an affordable, cost-effective, and safe marker that can enhance AI’s early detection. In the past years, the association between AI and eosinophilic inflammation has been well documented. Eosinophil cationic protein (ECP) is a specific marker for eosinophil activation. In this study, we aimed to assess the value of assaying serum ECP in detecting AI in patients with CRS.

Methods: Eighty-four patients with CRS were enrolled in this study, and they underwent an intravenous or oral aspirin (ASA) challenge test. Receiver operating characteristic curves were used to evaluate the diagnostic value of serum ECP level for the AI in patients with CRS and calculate the best diagnostic cut-off value.

Results: Using systemic ASA provocation, the prevalence of AI among patients with CRS was relatively high (43%). There was a significant difference in the mean serum ECP level in the two groups (positive group 19.3, negative group 8.6 µg/L, and P < .0125). Serum ECP level showed an acceptable discrimination value for predicting AI in patients with CRS (area under the curve = 0.622). The best diagnostic cut-off value and corresponding sensitivity and specificity were >13.9 µg/L (38.89%, 85.42%).

Conclusion: Assaying serum ECP in patients with CRS could help detect AI, especially when other more accurate tests are not available. 

Keywords:

Aspirin intolerance chronic rhinosinusitis eosinophil cationic protein systemic aspirin challenge test